75 related articles for article (PubMed ID: 12404338)
1. Comparison of the effect of levodopa and bromocriptine on naloxone-precipitated morphine withdrawal symptoms in mice.
Samini M; Fakhrian R; Mohagheghi M; Dehpour AR
Hum Psychopharmacol; 2000 Mar; 15(2):95-101. PubMed ID: 12404338
[TBL] [Abstract][Full Text] [Related]
2. Comparison of simultaneous administration of lithium with L-NAME or L-arginine on morphine withdrawal syndrome in mice.
Dehpour AR; Sadr SS; Nouroddini M; Shadan F; Nourozi A; Farahani M; Sahebgharani M
Hum Psychopharmacol; 2000 Mar; 15(2):87-93. PubMed ID: 12404337
[TBL] [Abstract][Full Text] [Related]
3. Morphine sex-dependently induced place conditioning in adult Wistar rats.
Karami M; Zarrindast MR
Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
[TBL] [Abstract][Full Text] [Related]
4. Effects of L-745,870, a dopamine D4 receptor antagonist, on naloxone-induced morphine dependence in mice.
Mamiya T; Matsumura T; Ukai M
Ann N Y Acad Sci; 2004 Oct; 1025():424-9. PubMed ID: 15542745
[TBL] [Abstract][Full Text] [Related]
5. Effect of alpha-adrenoreceptors in the control of spontaneous motility and morphine withdrawal syndrome.
Antonelli T; Morari M; Magri A; Bianchi C
Boll Soc Ital Biol Sper; 1991; 67(10-11):965-71. PubMed ID: 1687951
[TBL] [Abstract][Full Text] [Related]
6. Effects of aqueous, methanolic and chloroform extracts of rhizome and aerial parts of Valeriana officinalis L. on naloxone-induced jumping in morphine-dependent mice.
Sharifzadeh M; Hadjiakhoondi A; Khanavi M; Susanabadi M
Addict Biol; 2006 Jun; 11(2):145-51. PubMed ID: 16800827
[TBL] [Abstract][Full Text] [Related]
7. Modification of morphine-induced analgesia, tolerance and dependence by bromocriptine.
Gomaa AA; Mohamed LH; Ahmed HN
Eur J Pharmacol; 1989 Nov; 170(3):129-35. PubMed ID: 2620694
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
9. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
Zarrindast MR; Mohajeri S
Eur J Pharmacol; 2006 Dec; 552(1-3):90-8. PubMed ID: 17049514
[TBL] [Abstract][Full Text] [Related]
10. Ibogaine attenuation of morphine withdrawal in mice: role of glutamate N-methyl-D-aspartate receptors.
Leal MB; Michelin K; Souza DO; Elisabetsky E
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):781-5. PubMed ID: 12921910
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of morphine tolerance and dependence by aminoguanidine in mice.
Abdel-Zaher AO; Hamdy MM; Aly SA; Abdel-Hady RH; Abdel-Rahman S
Eur J Pharmacol; 2006 Jul; 540(1-3):60-6. PubMed ID: 16730698
[TBL] [Abstract][Full Text] [Related]
12. Effect of NMDA receptor antagonist on naloxone-precipitated withdrawal signs in cholestatic mice.
Dehpour AR; Samini M; Rastegar H; Ardeshiri AJ; Roushanzamir F; Jorjani M; Ahmadiani A
Hum Psychopharmacol; 2000 Apr; 15(3):213-218. PubMed ID: 12404334
[TBL] [Abstract][Full Text] [Related]
13. Morphine-induced antinociception in the formalin test: sensitization and interactions with D1 and D2 dopamine receptors and nitric oxide agents.
Zarrindast MR; Asgari-Afshar A; Sahebgharani M
Behav Pharmacol; 2007 May; 18(3):177-84. PubMed ID: 17426481
[TBL] [Abstract][Full Text] [Related]
14. The involvement of alpha 2A-adrenoceptors in morphine analgesia, tolerance and withdrawal in mice.
Ozdogan UK; Lähdesmäki J; Hakala K; Scheinin M
Eur J Pharmacol; 2004 Aug; 497(2):161-71. PubMed ID: 15306201
[TBL] [Abstract][Full Text] [Related]
15. Comparison of nitric oxide synthase inhibitors, phospholipase A2 inhibitor and free radical scavengers as attenuators of opioid withdrawal syndrome.
Mori T; Ito S; Matsubayashi K; Sawaguchi T
Behav Pharmacol; 2007 Dec; 18(8):725-9. PubMed ID: 17989510
[TBL] [Abstract][Full Text] [Related]
16. The effect of the serotonergic system on opioid withdrawal-like syndrome in a mouse model of cholestasis.
Dehpour AR; Sadeghipour HR; Nowroozi A; Akbarloo N
Hum Psychopharmacol; 2000 Aug; 15(6):423-428. PubMed ID: 12404304
[TBL] [Abstract][Full Text] [Related]
17. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA
Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219
[TBL] [Abstract][Full Text] [Related]
18. The role of dopamine in the expression of morphine withdrawal.
el-Kadi AO; Sharif SI
Gen Pharmacol; 1998 Apr; 30(4):499-505. PubMed ID: 9522166
[TBL] [Abstract][Full Text] [Related]
19. Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide.
Lewanowitsch T; Miller JH; Irvine RJ
Life Sci; 2006 Jan; 78(7):682-8. PubMed ID: 16102783
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms in dizocilpine-induced attenuation of development of morphine dependence: an association with cortical Ca2+/calmodulin-dependent signal cascade.
Hamdy MM; Noda Y; Miyazaki M; Mamiya T; Nozaki A; Nitta A; Sayed M; Assi AA; Gomaa A; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):263-70. PubMed ID: 15196794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
